BioRestorative Therapies Inc.
BRTX | NASDAQ
$2.65
-$0.06 (-2.21%)
Sep 22, 2026, 1:04 PM ET · Market open
Fiscal Quarter Period Ending | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 23.17K | 19.6K | 11.8K | 303.3K | 25K | 43.3K | 233.6K | 89.1K | 35K | 19.3K | 30.7K | 64.5K | 31.3K | 3.7K | 29K | 71.1K | 16K | 5K | 8K | 15K | 18K |
Cost of Revenue | 7.39K | 1.64K | 10.57K | 8.73K | 2.91K | 3.34K | 18.24K | 6.49K | n/a | 42.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 15.79K | 17.96K | 1.23K | 294.57K | 22.09K | 39.96K | 215.36K | 82.61K | 35K | -23.41K | 30.7K | 64.5K | 31.3K | 3.7K | 29K | 71.1K | 16K | 5K | 8K | 15K | 18K |
Operating Income | -3.39M | -3.83M | -3.71M | -3.31M | -4.81M | -2.69M | -2.29M | -2.47M | -4.11M | -3.22M | -3.1M | -3.12M | -5.78M | -4.68M | -4.61M | -4.63M | -5.05M | -4.01M | -3.69M | -3.56M | -15.05M |
Interest Income | 5.48K | 34.59K | 57.74K | 73.92K | 99.97K | 118.99K | 158.55K | 175.95K | 162.6K | 376.22K | 61.67K | 96.19K | 18.22K | 116.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -2.15M | -3.21M | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M | -4.03M | -2.22M | 1.17M | 4.77M | -5.71M | -7.17M | -4.35M | -4.66M | -4.68M | -4.82M | -20.4M | -4.18M | -4.06M | -15.65M |
Net Income | -2.15M | -3.21M | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M | -4.03M | -2.22M | 1.17M | 4.77M | -5.71M | -7.17M | -4.35M | -4.66M | -4.68M | -4.82M | -20.4M | -4.18M | -4.06M | -15.65M |
Selling & General & Admin | 1.48M | 1.22M | 1.12M | 1.37M | 3.12M | 1.07M | 1.18M | 1.26M | 3.09M | 2.52M | 2.33M | 2.28M | 4.58M | 4.01M | 3.65M | 3.62M | 4.29M | 3.85M | 3.46M | 3.41M | 14.87M |
Research & Development | 1.93M | 2.63M | 2.59M | 2.23M | 1.71M | 1.66M | 1.32M | 1.29M | 1.06M | 680.63K | 809.82K | 902.89K | 1.23M | 673.62K | 989.17K | 1.08M | 775.34K | 165.5K | 237.41K | 160.9K | 165.25K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39.59K |
Operating Expenses | 3.4M | 3.84M | 3.71M | 3.6M | 4.83M | 2.73M | 2.5M | 2.55M | 4.14M | 3.2M | 3.14M | 3.18M | 5.81M | 4.69M | 4.64M | 4.7M | 5.07M | 4.01M | 3.7M | 3.57M | 15.07M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 176.07K | n/a | n/a | n/a | n/a | 28.84K | 46.61K | 29.01K | 213.82K | 495.55K | 507.33K | 598.67K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 173.06K | n/a | n/a | n/a | -706 | n/a | n/a | n/a | n/a | n/a | 245 | 469 | 3.17K | n/a | 6.22K | 2.6K |
Cost & Expenses | 3.41M | 3.84M | 3.72M | 3.61M | 4.83M | 2.73M | 2.52M | 2.56M | 4.14M | 3.24M | 3.14M | 3.18M | 5.81M | 4.69M | 4.64M | 4.7M | 5.07M | 4.01M | 3.7M | 3.57M | 15.07M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 886.39K | 443.81K | 455.81K | 437.02K | 417.86K | 346K | 406.08K | 406.08K | 333.57K | 235.35K | 228.54K | 194.32K | 185.87K | 183.36K | 182.11K | 181.92K | 176.16K | 176.02K | 41.93K | 39.79K | 36.5K |
Shares Outstanding (Diluted) | 886.39K | 443.81K | 455.81K | 437.02K | 417.86K | 346K | 406.08K | 406.08K | 333.57K | 235.35K | 616.24K | 194.32K | 185.87K | 183.36K | 182.11K | 181.92K | 176.16K | 176.02K | 41.93K | 39.79K | 36.5K |
EPS (Basic) | -2.40 | -7.20 | -6.60 | -6 | -12.80 | -4.80 | -2.60 | -10 | -6.60 | 5 | 20.80 | -29.40 | -38.60 | -23.80 | -25.60 | -25.60 | -27.40 | -116 | -100 | -102.40 | -428.80 |
EPS (Diluted) | -2.40 | -7.20 | -6.60 | -6 | -12.80 | -4.80 | -2.60 | -10 | -6.60 | 5 | 7.80 | -29.40 | -38.60 | -23.80 | -25.60 | -25.60 | -27.40 | -116 | -100 | -102.40 | -428.80 |
EBITDA | -2.1M | -3.15M | -2.99M | -2.6M | -5.29M | -1.59M | -1.04M | -3.98M | -2.18M | 1.39M | -2.98M | -5.67M | -7.13M | -4.24M | -4.57M | -4.6M | -4.73M | -20.14M | -3.67M | -3.53M | -15.03M |
EBIT | -2.15M | -3.21M | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M | -4.03M | -2.22M | 1.35M | -3.02M | -5.71M | -7.17M | -4.35M | -4.63M | -4.63M | -4.79M | -20.19M | -3.69M | -3.56M | -15.05M |
Depreciation & Amortization | 52.39K | 52.84K | 52.62K | 52.75K | 51.78K | 50.37K | 48.27K | 47.71K | 42.71K | 42.71K | 42.15K | 41.53K | 39.35K | 104.88K | 60.24K | 31.52K | 55.02K | 50.56K | 21.58K | 21.83K | 24.2K |
Add to Watchlist
Select watchlists to add or remove BRTX